Combination therapy: intermittent sorafenib with bevacizumab yields activity and decreased toxicity

Title
Combination therapy: intermittent sorafenib with bevacizumab yields activity and decreased toxicity
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume 102, Issue 3, Pages 495-499
Publisher
Springer Nature
Online
2010-01-06
DOI
10.1038/sj.bjc.6605514

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now